Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $48,616. The most recent transaction as insider was on May 08, 2024, when has been sold 3,600 shares (Common Stock) at a price of $264.65 per share, resulting in proceeds of $952,739. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130
0% 3M change
0% 12M change
Total Value Held $48,616

MARTINE A ROTHBLATT Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 08 2024
SELL
Open market or private sale
$952,739 $264.65 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 08 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 07 2024
SELL
Open market or private sale
$949,932 $263.87 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 07 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 06 2024
SELL
Open market or private sale
$936,539 $260.15 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 06 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 03 2024
SELL
Open market or private sale
$935,352 $259.82 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 03 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 02 2024
SELL
Open market or private sale
$925,955 $257.21 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 02 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 01 2024
SELL
Open market or private sale
$898,200 $249.5 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
Apr 30 2024
SELL
Open market or private sale
$847,908 $235.53 p/Share
3,600 Reduced 96.51%
130 Common Stock
Apr 30 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
Apr 29 2024
SELL
Open market or private sale
$856,908 $238.03 p/Share
3,600 Reduced 96.51%
130 Common Stock
Apr 29 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
Apr 26 2024
SELL
Open market or private sale
$848,628 $235.73 p/Share
3,600 Reduced 96.51%
130 Common Stock
Apr 26 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
Apr 25 2024
SELL
Open market or private sale
$849,492 $235.97 p/Share
3,600 Reduced 96.51%
130 Common Stock
Apr 25 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
Apr 24 2024
SELL
Open market or private sale
$854,784 $237.44 p/Share
3,600 Reduced 96.51%
130 Common Stock
Apr 24 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
Apr 23 2024
SELL
Open market or private sale
$853,452 $237.07 p/Share
3,600 Reduced 96.51%
130 Common Stock
Apr 23 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
Apr 22 2024
SELL
Open market or private sale
$851,904 $236.64 p/Share
3,600 Reduced 96.51%
130 Common Stock
MAR

Martine A Rothblatt

Chairperson & CEO
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR